Cleerly ISCHEMIA vs A View LCS
AI Verdict
Choose Cleerly ISCHEMIA if…
Choose Cleerly ISCHEMIA if your primary goal is to non-invasively assess the likelihood of coronary artery ischemia at a vessel level using CCTA scans. This tool is ideal for physicians seeking detailed coronary plaque characterization, stenosis severity assessment, and non-invasive fractional flow reserve (FFR) estimation to guide personalized treatment plans for heart disease.
View Cleerly ISCHEMIA →Choose A View LCS if…
Choose AVIEW LCS if you require a comprehensive AI-powered platform for thoracic CT analysis, particularly for lung cancer screening programs. This tool is best suited for scenarios where a single low-dose CT scan needs to be leveraged for automated lung nodule detection, emphysema quantification, and coronary artery calcium scoring, providing a holistic view of thoracic health.
View A View LCS →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Cleerly ISCHEMIA | A View LCS |
|---|---|---|
| Pricing | Contact for details | Unknown |
| Deployment | Web-based platform; data transfer via Cleerly Proxy (VPN or virtual appliance) | Cloud-based, Hybrid solution, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker). It can also be integrated into standard reading environments (PACS), RIS (Radiological Information System), or used as a standalone third-party application or web-based application. |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
A View LCSAVIEW LCS emphasizes streamlined workflows with claims of up to 79% faster reading times and out-of-the-box installation requiring minimal IT support, directly addressing user efficiency and ease of deployment. While Cleerly ISCHEMIA offers interactive web-based reports and API integration, AVIEW LCS's focus on reducing radiologist workload and its UI/UX upgrades in version 2.0 give it a slight edge in overall usability.
Clinical Value
Cleerly ISCHEMIACleerly ISCHEMIA provides advanced cardiac analysis, including non-invasive fractional flow reserve (FFR) estimation and detailed coronary plaque characterization, which offers deeper insights into heart disease beyond traditional anatomical assessment. Its clinical utility is strongly supported by multiple trials (CREDENCE, PACIFIC) demonstrating high diagnostic accuracy and prognostic value for major adverse cardiac events, and it has a dedicated Category I CPT code for reimbursement.
Pricing & Value
Cleerly ISCHEMIAWhile both tools require direct contact for pricing, Cleerly ISCHEMIA's eligibility for the Category I CPTu00ae code 75580 for non-invasive FFR estimation provides a clear and standardized pathway for reimbursement. This directly enhances its financial value proposition for healthcare providers by facilitating billing and coverage. AVIEW LCS mentions time savings and ROI, but lacks a comparable direct billing mechanism in the provided information.
Enterprise Readiness
A View LCSAVIEW LCS offers superior enterprise readiness due to its highly flexible deployment options, including cloud, hybrid, local hardware, and virtualized solutions, catering to diverse IT infrastructures. It explicitly states compatibility with 'all major PACS' and 'out-of-the-box installation with minimal IT support,' indicating robust integration capabilities. Furthermore, Coreline Soft holds additional certifications like GDPR and ISO 27001, demonstrating a broader commitment to enterprise-level security and data governance.
Innovation
Cleerly ISCHEMIACleerly ISCHEMIA demonstrates a higher degree of innovation by offering non-invasive fractional flow reserve (FFR) estimation and comprehensive coronary plaque characterization from CCTA scans. This moves beyond anatomical assessment to provide functional insights and detailed disease phenotyping, which is a significant advancement in non-invasive cardiac diagnostics.
Support & Docs
TieBoth companies provide clear contact channels for customer support, including email and phone. Cleerly specifies operating hours and prioritizes after-hours needs, indicating a structured support system. Coreline Soft offers multiple regional contacts and a dedicated customer service email. Without specific details on service level agreements, documentation comprehensiveness, or user satisfaction metrics, it is not possible to definitively declare a winner.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Cleerly ISCHEMIA | A View LCS |
|---|---|---|
| Name | Cleerly ISCHEMIA | A View LCS |
| Primary Focus | Analyzes CCTA scans to non-invasively determine the likelihood of coronary artery ischemia at a vessel level, aiding physicians in personalized diagnosis and treatment planning for heart disease. | AI-powered medical imaging platform for comprehensive thoracic CT analysis, specializing in lung cancer screening, emphysema quantification, and coronary artery calcification detection from a single low-dose CT scan. |
| Company | Cleerly | Coreline Soft Co. |
| Target Specialties | Cardiology, Radiology | Cardiology, Pulmonology, Radiology |
| Key Cardiac Analysis Features | AI-enabled CCTA analysis, Non-invasive fractional flow reserve (FFR) estimation, Vessel-level ischemia likelihood determination, Coronary plaque characterization (volume, type, location), Stenosis severity assessment, 3D digital models of coronary arteries. | Coronary Artery Calcium (CAC) scoring (Agatston, volume, mass), Segmentation of major coronary arteries. |
| Key Lung Analysis Features | Not specified | Automated lung nodule detection and classification, Nodule volume quantification and measurement (3D), Lung-RADS scoring and reporting, Emphysema analysis and quantification (LAA). |
| Reporting Capabilities | Comprehensive interactive web-based reports, Integration with PowerScribe via API. | Automated comprehensive report generation (PDF, DICOM PDF, SR). |
Videos
Demos, reviews, and walkthroughs featuring Cleerly ISCHEMIA and A View LCS.
Frequently Asked Questions
More Comparisons
More matchups featuring Cleerly ISCHEMIA or A View LCS
Backers
Who funded each tool's parent company.